Technical Analysis for PEB - Pacific Edge Limited
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.100 | 0.00% | 0.000 |
PEB closed down 20.0 percent on Monday, November 18, 2024, on 11 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Nov 21
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
Fell Below 50 DMA | Bearish | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -20.00% | |
Gapped Down | Weakness | -20.00% | |
Narrow Range Bar | Range Contraction | -23.08% | |
Gapped Up | Strength | -23.08% |
Alert | Time |
---|---|
Down 10% | 3 days ago |
Down 2 ATRs | 3 days ago |
Down 1 ATR | 3 days ago |
Fell Below Previous Day's Low | 3 days ago |
Down 5% | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, Singapore, and internationally. It operates in two segments, Commercial and Research. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Cancers
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Cancers
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.48 |
52 Week Low | 0.07 |
Average Volume | 38,703 |
200-Day Moving Average | 0.102 |
50-Day Moving Average | 0.114 |
20-Day Moving Average | 0.129 |
10-Day Moving Average | 0.126 |
Average True Range | 0.008 |
RSI (14) | 35.90 |
ADX | 17.66 |
+DI | 32.212 |
-DI | 54.231 |
Chandelier Exit (Long, 3 ATRs) | 0.143 |
Chandelier Exit (Short, 3 ATRs) | 0.123 |
Upper Bollinger Bands | 0.147 |
Lower Bollinger Band | 0.111 |
Percent B (%b) | -0.31 |
BandWidth | 27.597 |
MACD Line | 0.000 |
MACD Signal Line | 0.003 |
MACD Histogram | -0.0033 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.100 | ||||
Resistance 3 (R3) | 0.100 | 0.100 | 0.100 | ||
Resistance 2 (R2) | 0.100 | 0.100 | 0.100 | 0.100 | |
Resistance 1 (R1) | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 |
Pivot Point | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 |
Support 1 (S1) | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 |
Support 2 (S2) | 0.100 | 0.100 | 0.100 | 0.100 | |
Support 3 (S3) | 0.100 | 0.100 | 0.100 | ||
Support 4 (S4) | 0.100 |